Abstract
Brain tumors are relatively rare: in post-mortem statistics, their incidence is approximately 6.7% in Eastern Germany and between 2.2 and 15.8% in other countries (for a review, see [68]). Only between 1 and 4% of all malignancies in adults are brain tumors. In children, the percentage is higher, ranging between 20 and 25%.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alavi JB, Alavi A, Goldberg HI, Dann R, Hickey W, Reivich M (1987) Sequential CT and PET studies in a patient with malignant glioma. Nucl Med Commun 8:457–468
Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M (1988) Positron emission tomography in patients with glioma - a predictor of prognosis. Cancer 62:1074–1078
Barker FG, Chang SM, Valk PE, Pounds TR, Prados MD (1997) 18 Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer 79:115–126
Bergström M, Collins VP, Ehrin E, Ericson K, Eriksson L, Greitz T, Halldin C, von Holst H, Langström B, Lilja A, Lundqvist H, Nagren K (1983) Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68GA] EDTA, [11C] glucose and [11C] methionine. J Comput Assist Tomogr 7:1062–1066
Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D (1989) Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 71:342–346
Black KL, Emerick T, Hoh C, Hawkins RA, Mazziotta J, Becker DP (1994) Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res 16:93–96
Borbely K, Fulham MJ, Brooks RA, Di Chiro G (1992) PET-fluorodeoxyglucose of cranial and spinal neuromas. J Nucl Med 33:1931–1934
Brucher JM (1993) Neuropathological diagnosis with stereotactic biopsies. Possibilities, difficulties and requirements. Acta Neurochir 124:37–39
Byrne TN (1994) Imaging of gliomas. Semin Oncol 21:162–171
Carvalho PA, Schwartz RB, Eben A et al. (1992) Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 77:565–570
Chandrasoma PT, Smith MM, Appuzzo MLJ (1989) Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery 24:160–165
Chang LT (1978) A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci NS-26/2:2780–2789
Cremerius U, Striepecke E, Henn W, Weis J, Mull M, Lippitz B, Gilsbach J, Schröder JM, Zang KD, Böcking A, Bull U (1994) 18FDG-PET in intracranial meningeomas versus grading, proliferation index, cellular density, and cytogenetic analysis. Nuklearmedizin 33:144–149
De Souza B, Brunetti A, Fulham MJ, Brooks RA, DeMichele D, Cook P, Nieman L, Doppman JL, Oldfield EH, Di Chiro G (1990) Pituitary microadenomas: a PET study. Radiology 177:39–44
De Witte O, Levivier M, Violon P, Salmon S, Damhaut P, Wikler D, Hildebrand J, Brotchi J, Goldman S (1996) Prognostic value of positron emission tomography with [18] fluorodeoxyglucose in the low-grade glioma. Neurosurgery 39:470–477
Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, Kessler RM (1995) Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195:47–52
Derlon JM, Bourdet C, Bustany P et al. (1989) [11C] L-Methionine uptake in gliomas. Neurosurgery 30:225–232
Di Chiro G, Oldfield E, Wright DC, De Michele D, Katz DA, Patronas NJ, Doppman JL, Larson SM, Ito M, Kufta CV (1988) Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathological studies. AJR 150:189–197
Di Chiro G (1986) Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 22:360–371
Di Chiro G, Hatazawa J, Katz DA, Rizzoli HV, De Michele DJ (1987) Glucose utilization by intracranial meningeomas as an index of tumor aggressivity and probability of recurrence: a PET study. Radiology 164:521–526
Doyle WK, Budinger TF, Valk PE, Levin VA, Gutin PH (1987) Differentiation of cerebral radiation necrosis from tumor recurrence by [18F1 FDG and 82Rb positron emission tomography. J Comput Assist Tomogr 11:563–570
Ericson K, Lilja A, Bergström M, Collins VP, Eriksson L, Ehrin E, von Holst H, Lundqvist H, Langström B, Mosskin M (1985) Positron emission tomography with ([11C] methyl)-L-methionine, [11C] D-glucose, and [68GA] EDTA in supratentorial brain tumors. J Comput Assist Tomogr 9:683–689
Francavilla TL, Miletich RS, Di Chiro G, Patronas NJ, Rizzoli HV, Wright DC (1989) Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. Neurosurgery 24:1–5
Glantz MJ, Hoffman JM, Coleman RE, Friedman AH, Hanson MW, Burger PC, Herndon JE II, Meisler WJ, Schold SC (1991) Identification of early recurrence of primary central nervous system tumors by [18F] fluorodeoxyglucose positron emission tomography. Ann Neurol 29:347–355
Goldman S, Levivier M, Pirotte B, Brucher J-M, Wikler D, Damhaut P, Stanus E, Brotchi J, Hildebrand J (1996) Regional glucose metabolism and histopathology of gliomas. Cancer 78:1098–1106
Goldman S, Levivier M, Pirotte B, Brucher J-M, Wikler D, Damhaut P, Dethy S, Brotchi J, Hildebrand J (1997) Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. J Nucl Med 38:1459–1462
Griffeth LK, Rich KM, Dehdashti F, Simpson JR, Fusselman MJ, McGuire AH, Siegel BA (1993) Brain metastases from non-central nervous system tumors: evaluation with PET [see comments]. Radiology 186:37–44
Guth-Tougelides B, Müller St, Mehdorn MM, Knust EJ, Dutschka K, Reiners C (1995) Anreicherung von DL-3-123I-Jod-Methyltyrosin in Hirntumorrezidiven. Nuklearmedizin 34:71–75
Herholz K, Pietrzyk U, Voges J, Schröder R, Halber M, Treuer H, Sturm V, Heiss W-D (1993) Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. J Neurosurg 79:853–858
Heiss P, Mayer S, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R (1999) Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)L-tyrosine in vitro and in vivo. J Nucl Med 40:1367–173
Herholz K, Hölzer T, Bauer B, Schröder R, Voges J, Ernestus RI, Mendoza G, WeberLuxenburger G, Löttgen J, Thiel A, Wienhard K, Heiss W-D (1998) C-11-Methionine PET for differential diagnosis of low-grade gliomas. Neurology 50:1316–1322
Hoffman JM, Waskin HA, Schifter T, Widemann B, Schröder R, Neubauer I, Heiss WD (1993) FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 34:567–575
Holthoff VA, Herholz K, Berthold F, Widemann B, Schröder R, Neubauer I, Heiss WD (1993) In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment. Cancer 72:1394–1403
Holzer T, Herholz K, Jeske J, Heiss WD (1993) FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr 17:681–687
Inoue T, Shibasaki T, Oriuchi N, Aoyagi K, Tomiyoshi K, Amano S, Mikuni M, Ida I, Aoki J, Endo K (1999) 18F alpha-methyl tyrosine PET studies in patients with brain tumors. J Nucl Med 40:399–405
Inoue T, Tomiyoshi K, Higuichi T, Ahmed K, Sarwar M, Aoyagi K, Amano S, Alyafei S, Zhang H, Endo K (1998) Biodistribution studies on L-3-[fluorine-18]fluoro-alphamethyl tyrosine: a potential tumor-detecting agent
Janus TJ, Kim E, Tilbury R, Bruner JM, Yung WKA (1993) Use of [18F] fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol 33:540–548
Kahn D, Follett KA, Bushnell DL, Nathan MA, Piper JG, Madsen M, Kirchner PT (1994) Diagnosis of recurrent brain tumor: Value of 201T1 SPECT vs 18F-fluorodeoxyglucose PET. AJR 163:1450–1465
Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, Luxen A, Reznik M (1998) Pre-operative evaluation of 54 gliomas by PET with fluorine-18fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 39:778–785
Kim CK, Alavi JB, Alavi A, Reivich M (1991) New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neuro-Oncol 10:85–91
Kramm CM, Sena-Esteves M, Barnett FH, Rainov NG, Schuback DE, Yu JS, Pechan PA, Paulus W, Chiocca EA, Breakefield XO (1995) Gene therapy for brain tumors. Brain Pathology 5:345–381
Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, Samnick S, Maasjosthusmann U, Lerch H, Gildehaus F-J, Wassmann H, Schober O (1996) Uptake of iodine-123-methyl tyrosine by gliomas and non-neoplastic brain lesions. Eur J Nucl Med 23:1345–1353
Kuwert T, Bartenstein P, Grünwald F, Herholz K, Larisch R, Sabri 0, Biersack H-J, Moser E, Müller-Gärtner H-W, Schober 0, Schwaiger M, Büll U, Heiss W-D (1998) Klinische Wertigkeit der Positronen-Emissions-Tomographie in der Neuromedizin. Nervenarzt 69:1045–1060
Kuwert T, Woesler B, Morgenroth C, Lerch H, Schäfers M, Palkovic P, Matheja P, Brandau W, Wassmann H, Schober O (1998) Diagnosis of recurrent glioma with SPECT and iodine-123-methyl tyrosine. J Nucl Med 39:23–27
Kole AC, Pruim J, Nieweg OE, van Ginkel RJ, Hoekstra HJ, Schraffordt Koops H, Vaalburg W (1997) PET with L-[1-carbon-11]-tyrosine to visualize tumors and measure protein synthesis rates. J Nucl Med 38:191–195
Langen K-J, Roosen N, Kuwert T, Herzog H, Kiwit JC, Rota Kops E, Muzik 0, Bock WJ, Feinendegen LE (1989) Early effects of intra-arterial chemotherapy in patients with brain tumours studied with PET: preliminary results. Nucl Med Commun 10:779–790
Leeds NE, Jackson EF (1994) Current imaging techniques for the evaluation of brain neoplasms. Curr Opin Oncol 6:254–261
Levivier M, Goldman S, Pirotte B, Brucher JM, Balériaux D, Luxen A, Hildebrand J, Brotchi J (1995) Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F] fluorodeoxy-glucose. J Neurosurg 82:445–452
Lilja A, Lundqvist H, Olsson Y, Spännare B, Gullberg P, Langström B (1989) Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions. Acta Radiol 30:121–128
Loiseau H, Bousquet P, Rivel J, Vital C, Kantor G, Rougier A, Dartigues JF, Cohadon F (1995) Astrocytomes de bas grade sustentoriels de l’adulte: Facteurs prognostics et indications thérapeutiques - á propos dune série de 141 patients. Neurochirurgie 41:38–51
Lorberboym M, Estok L, Machac J, German I, Sacher M, Feldman R, Wallach F, Dorfman D (1996) Rapid differential diagnosis of cerebral toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT. J Nucl Med 37:1150–1154
Lorberboym M, Wallach F, Estok L, Mosesson RE, Sacher M, Kim CK, Machac J (1998) Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients. J Nucl Med 39:1366–1369
Maciunas RJ, Kessler RM, Maurer C, Mandava V, Watt G, Smith G (1992) Positron emission tomography imaging directed stereotactic neurosurgery. Stereotact Funct Neurosurg 58:134–140
Maffioli L, Gasparini M, Chiti A, Gramaglia A, Mongioj V, Pozzi A, Bombardieri E (1996) Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumors. Eur J Nucl Med 23:308–311
McCormack BM, Miller DC, Budzilovich GN, Vorhees GJ, Ransohoff J (1992) Treatment and survival of low-grade astrocytoma in adults: 1977–1988. Neurosurgery 31:636–642
Mosskin M, Ericson K, Hindmarsh T, von Holst H, Collins VP, Bergström M, Eriksson L, Johnström P (1989) Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 30:225–232
Miettinen H, Kononen J, Haapasalo H, Helen P, Sallinen P, Harjuntausta T, Helin H, Alho H (1995) Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation. Cancer Res 55:2691–2695
Mineura K, Yasuda T, Kowada M, Ogawa T, Shishido F, Uemura K (1987) Positron emission tomography evaluation of radiochemotherapeutic effect on regional cerebral hemocirculation and metabolism in patients with gliomas. J Neuro-Oncol 5:277–285
Nagano N, Sasaki H, Aoyagi M, Hirakawa K (1993) Invasion of experimental brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol 86:117–125
Nariai T, Senda M, Ishii K, Maehara T, Wakabayashi S, Toyama H, Ishiwata K, Hirakawa K (1997) Three-dimensional imaging of cortical structure, function and glioma for tumor resection. J Nucl Med 38:1563–1568
Newsholme P, Newsholme EA (1989) Rates of utilization of glucose, glutamine, and oleate and formation of end-products by mouse peritoneal macrophages in culture. Biochem J 261:211–218
Ogawa T, Kanno I, Shishido F, Inugami A, Higano S, Fujita H, Murakami M, Uemura K, Yasui N, Mineura K, Kowada M (1991) Clinical value of PET with 18fluoro-deoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 32:197–202
Ogawa T, Shishido F, Kanno I et al. (1993) Cerebral glioma: evaluation with methionine PET. Radiology 186:45–53
Ogawa T, Shishido F, Kanno I et al. (1996) Clinical positron emission tomography for brain tumors: comparison of fluorodeoxyglucose 18F and L-methyl-11C-methionine. AJNR 17:345–353
Olivero WC, Dulebohn SC, Lister JR (1995) The use of PET in evaluating patients with primary brain tumors: is it useful? J Neurol Neurosurg Psychiatr 58:250–252
Oriuchi N, Tomiyoshi K, Inoue T et al. (1996) Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. J Nucl Med 37:457–462
Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, Larson SM (1985) Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62:816–822
Paulus W (1995) Tumoren des Nervensystems. In: Peiffer J, Schröder JM (eds) Neuropathologie. Morphologische Diagnostik der Krankheiten des Nervensystems, der Skelettmuskulatur and der Sinnesorgane. Springer, Berlin, pp 217–262
Paulus W, Peiffer J (1989) Intratumoral histologic heterogeneity of gliomas. Cancer 64:442–447
Pierce MA, Johnson MD, Maciunas RJ, Murray MJ, Allen GS, Harbison MA, Creasy JL, Kessler RM (1995) Evaluating contrast-enhancing brain lesions in patients with AIDS using positron emission tomography. Ann Intern Med 123:594–598
Riva P, Arista A, Franceschi G, Frattarelli M, Sturiale C, Riva N, Casi M, Rossitti R (1995) Local treatment of malignant gliomas by direct infusion of specific monoclonal antibodies labeled with 131I: comparison of the results obtained in recurrent and newly diagnosed brain tumors. Cancer Res 55 (23 Suppl): 5952S–5956S
Rozental JM, Levine RL, Nickles RJ (1991) Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance. J Neuro-Oncol 10:75–83
Rozental JM, Levine RL, Mehta MP, Kinsella TJ, Levin AB, Algan O, Mendoza M, Hanson JM, Schrader DA, Nickles RJ (1991) Early changes in brain tumor metabolism after treatment: the effects of stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 20:1053–1060
Rozental JM, Cohen JD, Mehta MP, Levine RL, Hanson JM, Nickles RJ (1993) Acute changes in glucose uptake after treatment: the effects of carmustine (13CNU) on human glioblastoma multiforme. J Neuro-Oncol 15:57–66
Ruiz A, Ganz WI, Post MJ, Camp A, Landy H, Mallin W, Sfakianakis GN (1994) Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. AJNR 15:1885–1894
Sasaki M, Ichija Y, Kuwabara Y, Otsuka M et al. (1990) Ringlike uptake of [18F]FDG in brain abscess: a PET study. J Comput Assist Tomogr 14:660–661
Shields AF, Grierson JR (1997) F-18-FLT can be used to image cell proliferation in vivo. J Nucl Med 38 (Suppl):249P
Schmidt D, Wunderlich G, Langen KJ et al. (1996) I-123-Methyl tyrosine (IMT) SPECT for evaluation of chemotherapy in cerebral gliomas. J Nucl Med 37 (Suppl): 354
Schober O, Meyer G-J, Duden C et al. (1987) Die Aufnahme von Aminosäuren in Hirntumoren mit der Positronenemissionstomographie als Indikator für die Beurteilung von Stoffwechselaktivität and Malignität. Fortschr Röntgenstr 147:503–509
Tjuvjajev J, Macapinlac H, Daghighian F, Scott A, Ginos J, Finn R, Kothari P, Desai R, Zhang J, Beattie B, Graham M, Larson St, Blasberg R (1994) Imaging of brain tumor proliferative activity with Iodine-131-iododeoxyuridine. J Nucl Med 35:1407–1417
Tovi M, Lilja A, Bergstrom M, Ericsson A, Bergstrom K, Hartman M (1990) Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiol 31:417–429
Valk PE, Budinger TF, Levin VA, Silver P, Gutin PH, Doyle WK (1988) PET of malignant cerebral tumors after interstitial brachytherapy. J Neurosurg 69:830–838
Van der Borght T, Pauwels S, Lambotte L, Labar D, de Maeght S, Stroobandt G, La-terre C (1994) Brain tumor imaging with PET and 2-[carbon-11] thymidine. J Nucl Med 35:974–982
Vick NA, Ciric IS, Eller TW, Cozzens JW, Walsh A (1989) Reoperation for malignant astrocytoma. Neurology 39:430–432
Villringer K, Jager H, Dichgans M, Ziegler S, Poppinger J, Herz M, Kruschke C, Minoshima S, Pfister HW, Schwaiger M (1995) Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr 19:532–536
Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, Stocklin G (1999) Synthesis and radiopharmacology of O-(2-[F18]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 40:205–212
Woesler B, Kuwert T, Morgenroth C, Matheja P, Palkovic S, Schäfers M, Vollet B, Schäfers K, Lerch H, Brandau W, Samnick S, Wassmann H, Schober O (1997) Non-invasive grading of primary brain tumors: results of a comparative study between SPECT with 123I-methyl tyrosine and PET with 18F-deoxyglucose. Eur J Nucl Med 24:428–434
Würker M, Herholz K, Voges J, Pietrzyk U, Treuer H, Bauer B, Sturm V, Heiss WD (1996) Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy. Eur J Nucl Med 23:583–586
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kuwert, T., Delbeke, D. (2000). Brain tumors. In: Wieler, H.J., Coleman, R.E. (eds) PET in Clinical Oncology. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57703-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-57703-1_11
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-63329-4
Online ISBN: 978-3-642-57703-1
eBook Packages: Springer Book Archive